Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda

The objective of this study was to determine the prevalence and some predictors for vaccine and non-vaccine types of HPV infections among bivalent HPV vaccinated and non-vaccinated young women in Uganda. This was a comparative cross sectional study 5.5 years after a bivalent HPV 16/18 vaccination (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumakech, Edward, Berggren, Vanja, Wabinga, Henry, Lillsunde-Larsson, Gabriella, Helenius, Gisela, Kaliff, Malin, Karlsson, Mats, Kirimunda, Samuel, Musubika, Caroline, Andersson, Sören
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970808/
https://www.ncbi.nlm.nih.gov/pubmed/27482705
http://dx.doi.org/10.1371/journal.pone.0160099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970808/
https://www.ncbi.nlm.nih.gov/pubmed/27482705
http://dx.doi.org/10.1371/journal.pone.0160099

Ejemplares similares